K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Increasing evidence, accrued in the past decades, indicates that the adverse outcomes of chronic kidney disease, such as kidney failure, cardiovascular disease, and premature death, can be prevented or delayed. Earlier stages of chronic kidney disease can be detected through laboratory testing. Treatment of earlier stages of chronic kidney disease is effective in slowing the progression toward kidney failure. Initiation of treatment for cardiovascular risk factors at earlier stages of chronic kidney disease should be effective in reducing cardiovascular disease events both before and after the onset of kidney failure.

[1]  G. Reboldi,et al.  High-normal serum creatinine concentration is a predictor of cardiovascular risk in essential hypertension. , 2001, Archives of internal medicine.

[2]  T. Greene,et al.  Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study. , 2000, Kidney international.

[3]  C. Mautalen,et al.  Effect of parathyroid hormone on bone resorption in uremic patients. , 1976, Medicina.

[4]  M. Praga,et al.  [Effect of pravastatin on hypercholesterolemia associated with proteinuria]. , 1994, Anales de medicina interna.

[5]  M. Christensen,et al.  Parathyroid function after renal transplantation: interrelationships between renal function, serum calcium and serum parathyroid hormone in normocalcemic long-term survivors. , 1977, Clinical nephrology.

[6]  Joël Ménard,et al.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.

[7]  R. Egdahl,et al.  Experience with a radioimmunoassay of parathyroid hormone in human sera. , 1968, Transactions of the Association of American Physicians.

[8]  P. Wilson,et al.  Thrombogenic Risk Factors for Cardiovascular Disease in Dialysis Patients , 1999 .

[9]  C. Pollock,et al.  Protein intake in renal disease. , 1997, Journal of the American Society of Nephrology : JASN.

[10]  P. Ballmer,et al.  Influence of acidosis on protein metabolism. , 1995, Nutrition.

[11]  Illiam,et al.  THE EFFECT OF NISOLDIPINE AS COMPARED WITH ENALAPRIL ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES AND HYPERTENSION , 2000 .

[12]  P. Aliabadi,et al.  Intact parathyroid hormone levels in renal insufficiency , 1995, Calcified Tissue International.

[13]  A. W. Gregory,et al.  Differential diagnosis of acute renal failure. , 1980, Clinical nephrology.

[14]  I. Cavill,et al.  Iron status as measured by serum ferritin: the marker and its limitations. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[15]  P. Watson,et al.  Total body water volumes for adult males and females estimated from simple anthropometric measurements. , 1980, The American journal of clinical nutrition.

[16]  T. Steinman,et al.  Nutritional status of patients with different levels of chronic renal insufficiency. Modification of Diet in Renal Disease (MDRD) Study Group. , 1989, Kidney international. Supplement.

[17]  M. Drezner,et al.  Altered divalent ion metabolism in early renal failure: role of 1,25(OH)2D. , 1985, Kidney international.

[18]  P. Rossini,et al.  New electrophysiological assessments for the early diagnosis of encephalopathy and peripheral neuropathy in chronic uraemia. , 1982, International journal of tissue reactions.

[19]  P. Kimmel,et al.  Quality of life and psychosocial relationships in patients with chronic renal insufficiency. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[20]  K. Borch-Johnsen,et al.  Coronary heart disease in young Type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors , 1987, Diabetologia.

[21]  R. Hays,et al.  Assessing health and quality of life outcomes in dialysis: a report on an Institute of Medicine workshop. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[22]  J. Adamson,et al.  Erythropoiesis in patients with renal failure undergoing chronic dialysis. , 1967, The New England journal of medicine.

[23]  H. Wedel,et al.  Plasma levels of lipoprotein (a) do not predict progression of human chronic renal failure. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[24]  N. Clyne,et al.  Quality of life in predialytic uremic patients , 1996, Quality of Life Research.

[25]  J. Madans,et al.  Proteinuria as a biomarker: risk of subsequent morbidity and mortality. , 1994, Environmental research.

[26]  W. Mitch,et al.  A SIMPLE METHOD OF ESTIMATING PROGRESSION OF CHRONIC RENAL FAILURE , 1976, The Lancet.

[27]  D. Manninen,et al.  Work disability, functional limitations, and the health status of kidney transplantation recipients posttransplant. , 1991, Clinical transplants.

[28]  T. Jogestrand,et al.  Effect of erythropoietin treatment on physical exercise capacity and on renal function in predialytic uremic patients. , 1992, Nephron.

[29]  D. Di Landro,et al.  Comparative outcome of patients on a conventional low protein diet versus a supplemented diet in chronic renal failure. , 1990, Contributions to nephrology.

[30]  A. Besarab,et al.  EFFECT OF CYCLOSPORINE AND DELAYED GRAFT FUNCTION ON POSTTRANSPLANTATION ERYTHROPOIESIS , 1985, Transplantation.

[31]  A. Caggiula,et al.  Registered dietitian time requirements in the Modification of Diet in Renal Disease Study. , 1995, Journal of the American Dietetic Association.

[32]  L. Gallo Cardiovascular Disease , 1995, GWUMC Department of Biochemistry Annual Spring Symposia.

[33]  T. Ikizler,et al.  Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: a prospective study. , 1999, Kidney international.

[34]  R. Berg,et al.  Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[35]  J. Bergström Nutrition and mortality in hemodialysis. , 1995, Journal of the American Society of Nephrology : JASN.

[36]  J. Eastwood,et al.  Some biochemical, histological, radiological and clinical features of renal osteodystrophy. , 1973, Kidney international.

[37]  V. Manninen,et al.  Effects of hypertension and dyslipidemia on the decline in renal function. , 1995, Hypertension.

[38]  G. Riccardi,et al.  Metabolic consequences of feeding a high-carbohydrate, high-fiber diet to diabetic patients with chronic kidney failure. , 1988, The American journal of clinical nutrition.

[39]  K. Forrest,et al.  Cardiovascular disease in insulin dependent diabetes mellitus: similar rates but different risk factors in the US compared with Europe. , 1998, International journal of epidemiology.

[40]  K. Lynn,et al.  Predicting renal survival in primary focal glomerulosclerosis from the time of presentation. , 1999, Kidney international.

[41]  E. Bonucci,et al.  Relationship between serum vitamin D metabolites and dietary intake of phosphate in patients with early renal failure. , 1987, Mineral and electrolyte metabolism.

[42]  M. Coco,et al.  Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[43]  J. Wikstrand,et al.  Urinary albumin excretion--a predictor of risk of cardiovascular disease. A prospective 10-year follow-up of middle-aged nondiabetic normal and hypertensive men. , 1996, American journal of hypertension.

[44]  R. Gottschalk,et al.  Erythropoietin and iron. , 1999, Kidney international. Supplement.

[45]  K. Borch-Johnsen,et al.  Microalbuminuria: Implications for micro- and macrovascular disease , 1992, Diabetes Care.

[46]  D. Petitti,et al.  Membranous nephropathy: predictors of terminal renal failure. , 1984, Nephron.

[47]  Efficacy and tolerability of recombinant human erythropoietin treatment in pre-dialysis patients: results of a multicenter study. , 1998, The International journal of artificial organs.

[48]  S. Massry,et al.  The physicochemical state and renal handling of divalent ions in chronic renal failure. , 1969, Archives of internal medicine.

[49]  D. Sherrard,et al.  Aluminum‐associated bone disease in chronic renal failure: High prevalence in a long‐term dialysis population , 1986, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[50]  K. Atsumi,et al.  Risk factors for vertebral fractures in renal osteodystrophy. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[51]  J. Zazgornik,et al.  High mortality and poor quality of life during predialysis period in type II diabetic patients with diabetic nephropathy. , 1994, Renal failure.

[52]  G. Torrance,et al.  Measurement of quality of life in end-stage renal disease: the time trade-off approach. , 1987, Clinical and investigative medicine. Medecine clinique et experimentale.

[53]  R. Prince,et al.  Determinants of intact parathyroid hormone and free 1,25-dihydroxyvitamin D levels in mild and moderate renal failure. , 1992, Nephron.

[54]  D. Manninen,et al.  The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. Cooperative Multicenter EPO Clinical Trial Group. , 1990, JAMA.

[55]  E. Lewis,et al.  Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. , 2001, The New England journal of medicine.

[56]  T A Louis,et al.  A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[57]  G. Maschio,et al.  Nutritional state in patients on long-term low-protein diet or with nephrotic syndrome. , 1989, Kidney international. Supplement.

[58]  R. Degowin,et al.  Effect of recombinant human erythropoietin on renal function in humans. , 1990, Kidney international.

[59]  F. Valderrábano,et al.  Controlled study on the improvement of quality of life in elderly hemodialysis patients after correcting end-stage renal disease-related anemia with erythropoietin. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[60]  J. Singer,et al.  Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[61]  E. Bonucci,et al.  Bone aluminum content in predialysis chronic renal failure and its relation with secondary hyperparathyroidism and 1,25(OH)2D3 treatment. , 1989, Mineral and electrolyte metabolism.

[62]  J. Yee,et al.  Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[63]  D. Schwartz,et al.  The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period. , 2001, Clinical nephrology.

[64]  G. Viberti,et al.  Glomerular Hyperfiltration in the Prediction of Nephropathy in IDDM: A 10-Year Follow-Up Study , 1996, Diabetes.

[65]  D. Levy,et al.  Proteinuria as a risk factor for cardiovascular disease and mortality in older people: a prospective study. , 2000, The American journal of medicine.

[66]  G. Viberti,et al.  Diabetic Nephropathy: Future avenue , 1992, Diabetes Care.

[67]  E. Lowrie,et al.  The relative contribution of measured variables to death risk among hemodialysis patients , 1994 .

[68]  D E Manyari,et al.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. , 1990, The New England journal of medicine.

[69]  J. Brod,et al.  Effect of correction of anemia on the glomerular filtration rate in chronic renal failure. , 1967, Israel journal of medical sciences.

[70]  Z. Massy,et al.  Dyslipidaemia and the progression of renal disease in chronic renal failure patients. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[71]  E. Araki,et al.  Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. , 1995, Diabetes research and clinical practice.

[72]  W. Mitch,et al.  Should protein intake be restricted in predialysis patients? , 1999, Kidney international.

[73]  P. Jungers,et al.  Effects of blood pressure and antihypertensive treatment on progression of advanced chronic renal failure. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[74]  R A Kronmal,et al.  Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study. , 1998, JAMA.

[75]  S. Kenny,et al.  Proteinuria and Mortality in Diabetes: the WHO Multinational Study of Vascular Disease in Diabetes , 1995, Diabetic medicine : a journal of the British Diabetic Association.

[76]  A. Kanagasabapathy,et al.  Prevalence of diabetic nephropathy in non-insulin dependent diabetics. , 1991, The Indian journal of medical research.

[77]  M. Elisaf,et al.  Increased Serum Lipoprotein(a) Levels in Patients with Early Renal Failure , 1999, Annals of Internal Medicine.

[78]  R. Tamarozzi,et al.  Early skeletal changes of the hand phalanges in patients with chronic renal failure. , 1985, The International journal of artificial organs.

[79]  H. Parving,et al.  Surrogate endpoints and renal protection: focus on microalbuminuria. , 1997, Blood pressure. Supplement.

[80]  S. Madsen,et al.  Degree and course of skeletal demineralization in patients with chronic renal insufficiency. , 1978, Scandinavian journal of urology and nephrology.

[81]  C. Jackson,et al.  MICROALBUMINURIA AS PREDICTOR OF VASCULAR DISEASE IN NON-DIABETIC SUBJECTS Islington Diabetes Survey , 1988, The Lancet.

[82]  V. Young,et al.  Long-term adaptive responses to dietary protein restriction in chronic renal failure. , 1995, The American journal of physiology.

[83]  A. Collins,et al.  Trends in anemia treatment with erythropoietin usage and patient outcomes. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[84]  R. Saracho,et al.  The importance of dietary calcium and phosphorous in the secondary hyperparathyroidism of patients with early renal failure. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[85]  L. Snetselaar,et al.  Factors associated with adherence to the dietary protein intervention in the Modification of Diet in Renal Disease Study. , 1995, Journal of the American Dietetic Association.

[86]  S. Wannamethee,et al.  Serum creatinine concentration and risk of cardiovascular disease: a possible marker for increased risk of stroke. , 1997, Stroke.

[87]  R. Foley,et al.  Clinical epidemiology of cardiovascular disease in chronic renal disease. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[88]  R. Whitehouse,et al.  Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease. , 1993, Kidney international.

[89]  Gordon H. Guyatt,et al.  Users' Guides to the Medical Literature: V. How to Use an Article About Prognosis , 1994 .

[90]  A. Robson,et al.  Control of phosphate excretion in uremic man. , 1968, The Journal of clinical investigation.

[91]  N. Kutner,et al.  REHABILITATION, AGING AND CHRONIC RENAL DISEASE , 1992, American journal of physical medicine & rehabilitation.

[92]  M. Suzuki,et al.  Renal osteodystrophy in early chronic renal failure. , 1980, Contributions to nephrology.

[93]  F. Locatelli,et al.  Prospective, randomised, multicentre trial of effect of protein restriction on progression of chronic renal insufficiency , 1991, The Lancet.

[94]  O. Tomonaga,et al.  Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting enzyme inhibitors in NIDDM patients , 1997, Diabetologia.

[95]  M. Laakso,et al.  Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects. , 1996, Stroke.

[96]  B. Bistrian Role of the systemic inflammatory response syndrome in the development of protein-calorie malnutrition in ESRD. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[97]  G. Beck,et al.  Effect of a ketoacid-aminoacid-supplemented very low protein diet on the progression of advanced renal disease: a reanalysis of the MDRD feasibility study. , 1998, Clinical nephrology.

[98]  A. Allegra,et al.  Effect of fluvastatin on proteinuria in patients with immunoglobulin A nephropathy , 2000, Clinical pharmacology and therapeutics.

[99]  E. Ritz,et al.  Bone histology in incipient and advanced renal failure. , 1976, Kidney international.

[100]  M. Ravid,et al.  Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. , 1998, Archives of internal medicine.

[101]  J. Coresh,et al.  Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. , 2000, Kidney international.

[102]  F. Llach,et al.  Hyperphosphatemia in end-stage renal disease patients: pathophysiological consequences. , 1999, Kidney international. Supplement.

[103]  C. Lasseur,et al.  Nutrition and outcome on renal replacement therapy of patients with chronic renal failure treated by a supplemented very low protein diet. , 2000, Journal of the American Society of Nephrology : JASN.

[104]  S. Zeger,et al.  The effect of a keto acid-amino acid supplement to a restricted diet on the progression of chronic renal failure. , 1984, The New England journal of medicine.

[105]  A. Krolewski,et al.  Hypercholesterolemia--a determinant of renal function loss and deaths in IDDM patients with nephropathy. , 1994, Kidney international. Supplement.

[106]  C. Hsu,et al.  Are we mismanaging calcium and phosphate metabolism in renal failure? , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[107]  Mei Wang,et al.  Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[108]  H. Bucht,et al.  Deterioration of GFR in IgA nephropathy as measured by 51Cr-EDTA clearance. , 1991, Kidney international.

[109]  J. Walls,et al.  The metabolic consequences of the correction of acidosis in uraemia. , 1989, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[110]  M. Haneda,et al.  Progression of diabetic nephropathy. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[111]  A. Michael,et al.  A solid phase fluorescent immunoassay for the measurement of human urinary albumin. , 1984, Kidney international.

[112]  K. Borch-Johnsen,et al.  Microalbuminuria: an important diagnostic tool. , 1994, Journal of diabetes and its complications.

[113]  E. Ritz,et al.  Calcium metabolism in early chronic renal failure: implications for the pathogenesis of hyperparathyroidism. , 1991, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[114]  A. Cupisti,et al.  Nutritional treatment of renal failure in type 1 diabetic nephropathy. , 1988, Clinical nephrology.

[115]  W. O'Fallon,et al.  Primary Hyperparathyroidism and the Risk of Fracture: A Population‐Based Study , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[116]  A. Levin,et al.  Cardiovascular disease in chronic renal insufficiency. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[117]  R M Hakim,et al.  Initiation of dialysis. , 1994, Advances in nephrology from the Necker Hospital.

[118]  B. Myers,et al.  Slope of serial glomerular filtration rate and the progression of diabetic glomerular disease. , 1993, Journal of the American Society of Nephrology : JASN.

[119]  G. Sundkvist,et al.  Relationships among glomerular filtration rate, albuminuria, and autonomic nerve function in insulin-dependent and non-insulin-dependent diabetes mellitus. , 1997, Journal of diabetes and its complications.

[120]  S. Madsen,et al.  Renal handling of phosphate in relation to serum parathyroid hormone levels. , 2009, Acta medica Scandinavica.

[121]  M. Goel,et al.  Observations on peripheral neuropathy in chronic uraemics. , 1978, Journal of Association of Physicians of India.

[122]  C. Tetta,et al.  C REACTIVE PROTEIN IN PATIENTS WITH CHRONIC RENAL DISEASES , 2001, Renal failure.

[123]  M. Walser,et al.  Can renal replacement be deferred by a supplemented very low protein diet? , 1999, Journal of the American Society of Nephrology : JASN.

[124]  J. Kanis,et al.  Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure , 1995, BMJ.

[125]  A. Dusso,et al.  Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro. , 1996, The Journal of clinical investigation.

[126]  K. Forrest,et al.  The changing course of diabetic nephropathy: low-density lipoprotein cholesterol and blood pressure correlate with regression of proteinuria. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[127]  N. Kutner Assessing end-stage renal disease patients' functioning and well-being: measurement approaches and implications for clinical practice. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[128]  H. Malluche,et al.  Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[129]  A. Barrientos,et al.  Cardiovascular effects of recombinant human erythropoietin in predialysis patients. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[130]  W. G. Walker Hypertension-related renal injury: a major contributor to end-stage renal disease. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[131]  S. Nielsen,et al.  Microalbuminuria in non-insulin-dependent diabetes. , 1992, Clinical nephrology.

[132]  E. Bonucci,et al.  Metabolic acidosis and osteodystrophic bone disease in predialysis chronic renal failure: effect of calcitriol treatment. , 1995, Mineral and electrolyte metabolism.

[133]  S. Downie,et al.  Correction of acidosis in hemodialysis decreases whole-body protein degradation. , 1997, Journal of the American Society of Nephrology : JASN.

[134]  A. Caggiula,et al.  Nutrition intervention program of the Modification of Diet in Renal Disease Study: a self-management approach. , 1995, Journal of the American Dietetic Association.

[135]  G. de Klerk,et al.  Serum erythropoietin (ESF) titers in anemia of chronic renal failure. , 1982, The Journal of laboratory and clinical medicine.

[136]  A R Nissenson,et al.  The effects of recombinant human erythropoietin on functional health and well-being in chronic dialysis patients. , 1996, Journal of the American Society of Nephrology : JASN.

[137]  G. Mintz,et al.  Cardiovascular hemodynamic effects of correction of anemia of chronic renal failure with recombinant-human erythropoietin. , 1991, Transplantation proceedings.

[138]  K. Johansen,et al.  Physical functioning and exercise capacity in patients on dialysis. , 1999, Advances in renal replacement therapy.

[139]  P. Eskildsen,et al.  Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure. , 1999, Kidney international.

[140]  G. Beck,et al.  Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. , 1997, Kidney international.

[141]  A. Donker,et al.  Clinical usefulness of measurement of urinary albumin excretion in diabetes mellitus. , 1993, The Netherlands journal of medicine.

[142]  F. Dekker,et al.  Quality of Life in Predialysis End-Stage Renal Disease Patients at the Initiation of Dialysis Therapy , 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[143]  J. Fisher Mechanism of the anemia of chronic renal failure. , 1980, Nephron.

[144]  H. Gerstein,et al.  The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. , 1997, Archives of internal medicine.

[145]  A. Levin,et al.  Defining a renal anemia management period. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[146]  J. Delmez,et al.  Pathogenesis of secondary hyperparathyroidism. , 1999, Kidney international. Supplement.

[147]  O. Knoll,et al.  Detection of uremic neuropathy by reflex response latency , 1980, Journal of the Neurological Sciences.

[148]  P. Rampal,et al.  Quality of life in long-term home enteral nutrition patients. , 2000, Clinical nutrition.

[149]  S. J. Poirier Preserving the diabetic kidney. , 1998, The Journal of family practice.

[150]  B. V. Shah,et al.  Spontaneous changes in the rate of decline in reciprocal serum creatinine: errors in predicting the progression of renal disease from extrapolation of the slope. , 1992, Journal of the American Society of Nephrology : JASN.

[151]  W. Mitch,et al.  Nutritional Considerations in the Treatment of Patients with Chronic Uremia , 1998, Mineral and Electrolyte Metabolism.

[152]  R. Prince,et al.  A Case–Control Study of Quality of Life and Functional Impairment in Women with Long–Standing Vertebral Osteoporotic Fracture , 1999, Osteoporosis International.

[153]  Y. Boirie,et al.  Alterations of protein metabolism by metabolic acidosis in children with chronic renal failure. , 2000, Kidney international.

[154]  A. Kliger,et al.  Clinical practice guidelines in end-stage renal disease: a strategy for implementation. , 1999, Journal of the American Society of Nephrology : JASN.

[155]  K. Maurer,et al.  Sample design: Third National Health and Nutrition Examination Survey. , 1992, Vital and health statistics. Series 2, Data evaluation and methods research.

[156]  M. Olson,et al.  Dietary satisfaction correlated with adherence in the Modification of Diet in Renal Disease Study. , 1995, Journal of the American Dietetic Association.

[157]  G. Remuzzi,et al.  Chronic proteinuric nephropathies. II. Outcomes and response to treatment in a prospective cohort of 352 patients: differences between women and men in relation to the ACE gene polymorphism. Gruppo Italiano di Studi Epidemologici in Nefrologia (Gisen) , 2000, Journal of the American Society of Nephrology : JASN.

[158]  B. Panayiotou,et al.  Microalbuminuria: Pathogenesis, Prognosis and Management , 1994, The Journal of international medical research.

[159]  M. Christensen,et al.  Bone composition and parathyroid function in chronic renal failure. , 2009, Acta medica Scandinavica.

[160]  C. Thompson,et al.  Microalbuminuria: A Marker to Increased Renal and Cardiovascular Risk in Diabetes Mellitus , 1997, Scottish medical journal.

[161]  J. Goodwin,et al.  The association between chronic diseases and depressive symptomatology in older Mexican Americans. , 1998, The journals of gerontology. Series A, Biological sciences and medical sciences.

[162]  M. Marre,et al.  Microalbuminuria as a predictor of a drop in glomerular filtration rate in subjects with non-insulin-dependent diabetes mellitus and hypertension. , 1997, Clinical nephrology.

[163]  T. Lehtimäki,et al.  Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism and Diabetic Albuminuria in Patients with NIDDM Followed Up for 9 Years , 1998, Nephron.

[164]  S. Massry,et al.  Skeletal resistance to parathyroid hormone in renal failure. Studies in 105 human subjects. , 1973, Annals of internal medicine.

[165]  B. Brenner,et al.  Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. , 2001, The New England journal of medicine.

[166]  J. Dillon The quantitative relationship between treated blood pressure and progression of diabetic renal disease. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[167]  A. S. Appel,et al.  Acute Renal Failure , 1960, Advances in Experimental Medicine and Biology.

[168]  H. Parving Diabetic hypertensive patients. Is this a group in need of particular care and attention? , 1999, Diabetes care.

[169]  M. Blaufox,et al.  Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. , 1989, Hypertension.

[170]  Y. Pei,et al.  Predicting chronic renal insufficiency in idiopathic membranous glomerulonephritis. , 1992, Kidney international.

[171]  P. J. Friedman Serum creatinine: an independent predictor of survival after stroke , 1991, Journal of internal medicine.

[172]  J. Achard,et al.  Risk factors of renal failure progression two years prior to dialysis. , 1999, Clinical nephrology.

[173]  B. Lindholm,et al.  Malnutrition, cardiac disease, and mortality: an integrated point of view. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[174]  Ki-Up Lee,et al.  Prevalence and Associated Features of Albuminuria in Koreans with NIDDM , 1995, Diabetes Care.

[175]  E. Zeitler,et al.  Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[176]  W. Mitch,et al.  Factors causing malnutrition in patients with chronic uremia. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[177]  M. Buset,et al.  Radioimmunoassay of erythropoietin in chronic uraemia or anephric patients. , 2009, Scandinavian journal of haematology.

[178]  M. Rudnick,et al.  Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[179]  G. Beck,et al.  Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group. , 1995, Journal of the American Society of Nephrology : JASN.

[180]  L. Oldrizzi,et al.  Nutritional assessment in patients with early renal insufficiency on long-term low protein diet. , 1986, Contributions to nephrology.

[181]  L. Magder,et al.  A crossover comparison of progression of chronic renal failure: ketoacids versus amino acids. , 1993, Kidney international.

[182]  S. Nielsen,et al.  The clinical course of renal function in NIDDM patients with normo‐ and microalbuminuria , 1997, Journal of internal medicine.

[183]  B. Tönshoff,et al.  Derangements of the somatotropic hormone axis in chronic renal failure. , 1997, Kidney international. Supplement.

[184]  G. Jerums,et al.  Microalbuminuria: Prognostic and Therapeutic Implications in Diabetes Mellitus , 1994, Diabetic medicine : a journal of the British Diabetic Association.

[185]  J. Walls,et al.  Metabolic acidosis and skeletal muscle adaptation to low protein diets in chronic uremia. , 1991, Kidney international.

[186]  P. Jungers,et al.  Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[187]  C. Mogensen,et al.  Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas , 1999, Diabetologia.

[188]  F. Bartter,et al.  Hyperparathyroidism and renal failure. , 1955, Bulletin. Tufts-New England Medical Center.

[189]  A. Greenberg,et al.  Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure. , 1988, The Journal of clinical endocrinology and metabolism.

[190]  F. Port,et al.  Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[191]  D. Bushinsky The contribution of acidosis to renal osteodystrophy. , 1995, Kidney international.

[192]  P. Stenvinkel,et al.  Apo(a)-isoform size, nutritional status and inflammatory markers in chronic renal failure. , 1998, Kidney international.

[193]  C. Moore,et al.  Characterization of the anemia associated with chronic renal insufficiency. , 1958, The American journal of medicine.

[194]  David C. Murray,et al.  Outcome and risk factors for left ventricular disorders in chronic uraemia. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[195]  Joni K. Evans,et al.  Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. The Collaborative Study Group. , 1996, Kidney international.

[196]  Giuseppe Mancia,et al.  Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT) , 2000, The Lancet.

[197]  V. Rigalleau,et al.  Outcome of nutritional status and body composition of uremic patients on a very low protein diet. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[198]  G. D'Amico,et al.  Dietary control may influence several risk factors in patients with chronic renal failure. , 1990, Contributions to nephrology.

[199]  R. Gleason,et al.  Autonomic function in type I diabetes mellitus complicated by nephropathy. A cross-sectional analysis in the presymptomatic phase. , 1995, American journal of hypertension.

[200]  M. Hori,et al.  Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[201]  W. Keane Proteinuria: its clinical importance and role in progressive renal disease. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[202]  R. McGonigle,et al.  Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency. , 1984, Kidney international.

[203]  E. Ritz,et al.  Nephropathy in patients with type 2 diabetes mellitus. , 1999, The New England journal of medicine.

[204]  J. Rastad,et al.  Serum levels of parathyroid hormone are related to the mortality and severity of illness in patients in the emergency department , 1997, European journal of clinical investigation.

[205]  N. Powe,et al.  Formal literature review of quality-of-life instruments used in end-stage renal disease. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[206]  J. Delmez,et al.  Hyperphosphatemia: its consequences and treatment in patients with chronic renal disease. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[207]  G. Bakris,et al.  Effect of calcium channel or beta-blockade on the progression of diabetic nephropathy in African Americans. , 1997, Hypertension.

[208]  M. A. Ferreira,et al.  Diagnosis of renal osteodystrophy: when and how to use biochemical markers and non-invasive methods; when bone biopsy is needed. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[209]  J. Stoves,et al.  A randomized study of oral vs intravenous iron supplementation in patients with progressive renal insufficiency treated with erythropoietin. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[210]  P. Raskin,et al.  Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus. , 1991, The New England journal of medicine.

[211]  W. Oertel,et al.  Polysomnographic sleep measures in patients with uremic and idiopathic restless legs syndrome , 1998, Movement disorders : official journal of the Movement Disorder Society.

[212]  G. Viberti,et al.  Microalbuminuria Predicts Mortality in Noninsulin‐dependent Diabetes , 1984, Diabetic medicine : a journal of the British Diabetic Association.

[213]  K. Koch,et al.  Serum erythropoietin concentration in chronic renal failure: relationship to degree of anemia and excretory renal function. , 1979, Blood.

[214]  C. Winearls Recombinant human erythropoietin: 10 years of clinical experience. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[215]  K. Lau,et al.  Phosphate excess and progressive renal failure: the precipitation-calcification hypothesis. , 1989, Kidney international.

[216]  D. Silverberg,et al.  Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[217]  J. Zazgornik,et al.  Similar rate of progression in the predialysis phase in type I and type II diabetes mellitus. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[218]  G. Beck,et al.  Cardiovascular disease risk factors in chronic renal insufficiency. , 2002, Clinical nephrology.

[219]  P. Stenvinkel,et al.  Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. , 1999, Kidney international.

[220]  D. Burn,et al.  Neurology and the kidney , 1998, Journal of neurology, neurosurgery, and psychiatry.

[221]  Y. Kawaguchi,et al.  Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients. , 1997, Nephron.

[222]  P. Deoreo,et al.  Hemodialysis patient-assessed functional health status predicts continued survival, hospitalization, and dialysis-attendance compliance. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[223]  V. Campese,et al.  Mechanisms of autonomic nervous system dysfunction in uremia. , 1981, Kidney international.

[224]  E. Friedman,et al.  Dismal rehabilitation in geriatric inner-city hemodialysis patients. , 1994, JAMA.

[225]  S. Yusuf,et al.  Renal Insufficiency as a Predictor of Cardiovascular Outcomes and the Impact of Ramipril: The HOPE Randomized Trial , 2001, Annals of Internal Medicine.

[226]  R. Tisch,et al.  Insulin-Dependent Diabetes Mellitus , 1996, Cell.

[227]  C. E. Mogensen,et al.  Proliferative diabetic retinopathy: at risk patients identified by early detection of microalbuminuria , 1985, Acta ophthalmologica.

[228]  H. Wedel,et al.  Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[229]  D. Sherrard,et al.  Evidence that serum phosphate is independently associated with serum PTH in patients with chronic renal failure. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[230]  P. Jungers,et al.  Factors affecting progression in advanced chronic renal failure. , 1993, Clinical nephrology.

[231]  Z. Varghese,et al.  Simvastatin therapy for hypercholesterolemic patients with nephrotic syndrome or significant proteinuria. , 1993, Kidney international.

[232]  A. Zanchetti,et al.  Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. , 2001, Journal of the American Society of Nephrology : JASN.

[233]  A. Cupisti,et al.  Nutritional state of severe chronic renal failure patients on a low-protein supplemented diet. , 1990, Contributions to nephrology.

[234]  P. Fröhling,et al.  Evaluation of nutritional status in the GDR trial. , 1990, Contributions to nephrology.

[235]  W. Tierney,et al.  Clinical correlates of functional status in patients with chronic renal insufficiency. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[236]  J. Adamson,et al.  Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial. , 1989, Annals of internal medicine.

[237]  A. Donker,et al.  Protein-restricted diets in chronic renal failure: a four year follow-up shows limited indications. , 1989, Kidney international. Supplement.

[238]  M. Miller,et al.  Serum immunoreactive erythropoietin levels in patients with polycystic kidney disease as compared with other hemodialysis patients. , 1985, Nephron.

[239]  F. V. Lente,et al.  Serum lipid changes associated with modified protein diets: results from the feasibility phase of the Modification of Diet in Renal Disease Study. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[240]  D. Sherrard Control of Renal Bone Disease , 1994 .

[241]  L. Chambless,et al.  A community-based study of explanatory factors for the excess risk for early renal function decline in blacks vs whites with diabetes: the Atherosclerosis Risk in Communities study. , 1999, Archives of internal medicine.

[242]  G. Guyatt,et al.  Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. , 1994, JAMA.

[243]  L. Niskanen,et al.  Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial , 1999, The Lancet.

[244]  R. McGonigle,et al.  Potential role of parathyroid hormone as an inhibitor of erythropoiesis in the anemia of renal failure. , 1984, The Journal of laboratory and clinical medicine.

[245]  H. Klehr,et al.  Immunoreactive parathyroid hormone in early and advanced renal failure. , 1982, Nephron.

[246]  K. Latta,et al.  Chronic Renal Failure: An Overview from a Pediatric Perspective , 1998, Nephron.

[247]  E. Boyko,et al.  Responsiveness of the SF-36 among veterans with diabetes mellitus. , 2000, Journal of diabetes and its complications.

[248]  A. Manatunga,et al.  Mechanisms permitting nephrotic patients to achieve nitrogen equilibrium with a protein-restricted diet. , 1997, The Journal of clinical investigation.

[249]  A. Cheung,et al.  Determinants of serum 1,25(OH)2D levels in renal disease. , 1983, Kidney international.

[250]  G. Hughes,et al.  THE SYSTOLIC HYPERTENSION IN THE ELDERLY PROGRAM , 1982 .

[251]  A. Alzaid Microalbuminuria in Patients With NIDDM: An Overview , 1996, Diabetes Care.

[252]  S. Massry,et al.  On the mechanism of secondary hyperparathyroidism in moderate renal insufficiency. , 1985, The Journal of clinical endocrinology and metabolism.

[253]  O. Pedersen,et al.  Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study , 1999, The Lancet.

[254]  S. Greenfield,et al.  The Medical Outcomes Study. An application of methods for monitoring the results of medical care. , 1989, JAMA.

[255]  G. Woodrow,et al.  Measurement of body composition in chronic renal failure: comparison of skinfold anthropometry and bioelectrical impedance with dual energy X-ray absorptiometry. , 1996, European journal of clinical nutrition.

[256]  G. Remuzzi,et al.  Abnormal permeability to proteins and glomerular lesions: a meta-analysis of experimental and human studies. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[257]  B. Fagerberg,et al.  Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus. Risk Factor Intervention Study Group. , 1997, The American journal of cardiology.

[258]  P. Whelton,et al.  Creatinine clearance as a measure of GFR in screenees for the African-American Study of Kidney Disease and Hypertension pilot study. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[259]  H. Saha Calcium and vitamin D homeostasis in patients with heavy proteinuria. , 1994, Clinical nephrology.

[260]  M. Gall Albuminuria in non-insulin-dependent diabetes mellitus. Prevalence, causes, and consequences. , 1997, Danish medical bulletin.

[261]  V. Nielsen The peripheral nerve function in chronic renal failure. VI. The relationship betweeen sensory and motor nerve conduction and kidney function, azotemia, age, sex, and clinical neuropathy. , 1973, Acta medica Scandinavica.

[262]  F. Port,et al.  Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[263]  E. Slatopolsky,et al.  The role of phosphorus restriction in the prevention of secondary hyperparathyroidism in chronic renal disease. , 1973, Kidney international.

[264]  A. Kliger Clinical practice guidelines and performance measures in ESRD. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[265]  Jasper Lin,et al.  Effect of long-term low-dose aluminum-containing agents on hemoglobin synthesis in patients with chronic renal insufficiency. , 1996, Nephron.

[266]  S. Leurgans,et al.  Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy. , 1996, Kidney international.

[267]  K. Baboolal,et al.  Incidence of end-stage renal disease in medically treated patients with severe bilateral atherosclerotic renovascular disease. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[268]  P. Vestergaard,et al.  Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism , 2000, BMJ : British Medical Journal.

[269]  A. Kausz,et al.  Anemia management in patients with chronic renal insufficiency. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[270]  T. Kigoshi,et al.  Reversed circadian blood pressure rhythm independently predicts endstage renal failure in non-insulin-dependent diabetes mellitus subjects. , 1999, Journal of diabetes and its complications.

[271]  M. Emoto,et al.  Diabetes mellitus increases the severity of anemia in non-dialyzed patients with renal failure. , 1998, Journal of nephrology.

[272]  M. Rocco,et al.  Cross-sectional study of quality of life and symptoms in chronic renal disease patients: the Modification of Diet in Renal Disease Study. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[273]  M. Budisavljevic,et al.  Calciphylaxis in chronic renal failure. , 1996, Journal of the American Society of Nephrology : JASN.

[274]  E. Bonucci,et al.  Renal bone disease in 76 patients with varying degrees of predialysis chronic renal failure: a cross-sectional study. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[275]  M. Walser,et al.  Progression of chronic renal failure in man. , 1990, Kidney international.

[276]  P. Kimmel,et al.  Perception of illness and depression in chronic renal disease. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[277]  F. Takaku,et al.  Serum erythropoietin titers in the anemia of chronic renal failure and other hematological states. , 1987, International journal of cell cloning.

[278]  A. Levey,et al.  "U" curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc. , 1998, Kidney international.

[279]  P. Andersen,et al.  The effect of proteinuria on relative mortality in Type 1 (insulin-dependent) diabetes mellitus , 1985, Diabetologia.

[280]  Tom Greene,et al.  Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[281]  M. Fujisawa,et al.  Assessment of health-related quality of life in renal transplant and hemodialysis patients using the SF-36 health survey. , 2000, Urology.

[282]  V. Cambi,et al.  The influence of glomerular filtration rate on uremic polyneuropathy. , 1980, Clinical nephrology.

[283]  G. D'Amico,et al.  Uremic polyneuropathy: a clinical and electrophysiological study in 135 short- and long-term hemodialyzed patients. , 1991, Clinical nephrology.

[284]  Z. Massy,et al.  Importance of homocysteine, lipoprotein (a) and non-classical cardiovascular risk factors (fibrinogen and advanced glycation end-products) for atherogenesis in uraemic patients. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[285]  A. Besarab,et al.  Erythropoietin response to blood loss in hemodialysis patients in blunted but preserved. , 1994, ASAIO journal.

[286]  H. Parving,et al.  Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study , 1997, BMJ.

[287]  C. Mogensen,et al.  Microalbuminuria as predictor of increased mortality in elderly people. , 1990, BMJ.

[288]  T. Sugimoto,et al.  Effect of dietary protein restriction on proteinuria in non-insulin-dependent diabetic patients with nephropathy. , 1991, Journal of nutritional science and vitaminology.

[289]  Y. Takamitsu,et al.  Effect of low protein diet and surplus of essential amino acids on the serum concentration and the urinary excretion of methylguanidine and guanidinosuccinic acid in chronic renal failure. , 1979, Nephron.

[290]  Y. Pei,et al.  The spectrum of bone disease in end-stage renal failure--an evolving disorder. , 1993, Kidney international.

[291]  G. Savazzi Nerve conduction times in uremia. , 1981, The International journal of artificial organs.

[292]  S. Donnelly,et al.  Erythropoietin deficiency in hyporeninemia. , 1999, American Journal of Kidney Diseases.

[293]  L. Dworkin,et al.  Antihypertensive drugs, dietary salt, and renal protection: how low should you go and with which therapy? , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[294]  R. Parker,et al.  Spontaneous dietary protein intake during progression of chronic renal failure. , 1995, Journal of the American Society of Nephrology : JASN.

[295]  T. Akiba,et al.  Levels of serum 1,25(OH)2D in patients with pre-dialysis chronic renal failure. , 1996, The Tohoku journal of experimental medicine.

[296]  T. Ikizler,et al.  Nutrition in end-stage renal disease. , 1996, Kidney international.

[297]  Z. Taralov,et al.  Erythrocyte ferritin levels in chronic renal failure patients. , 1998, Folia medica.

[298]  D. Isacson,et al.  Hypertension and health-related quality of life. an epidemiological study in Sweden. , 2001, Journal of clinical epidemiology.

[299]  J. Kopple,et al.  Energy expenditure in patients with chronic renal failure. , 1986, Kidney international.

[300]  L. Lins,et al.  Progressive decline in renal function induces a gradual decrease in total hemoglobin and exercise capacity. , 1994, Nephron.

[301]  G. Beck,et al.  The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. , 1994, The New England journal of medicine.

[302]  D Hernández,et al.  Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH. , 1995, Kidney international.

[303]  C. Mogensen,et al.  Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. , 1984, The New England journal of medicine.

[304]  M. Emoto,et al.  Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure. , 1999, Kidney international.

[305]  P. R. de Cotret Relationships among diabetes, microalbuminuria, and ACE inhibition. , 1998, Journal of cardiovascular pharmacology.

[306]  C. Catena,et al.  Lipoprotein(a) and apolipoprotein(a) isoforms and proteinuria in patients with moderate renal failure. , 1999, Kidney international.

[307]  P. Messa,et al.  The calcitonin-calcium relation curve and calcitonin secretory parameters in renal patients with variable degrees of renal function. , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[308]  A. Besarab,et al.  Dynamics of erythropoiesis following renal transplantation. , 1987, Kidney international.